Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Analyst Predicts Bitcoin Boom Due to U.S. Debt, Money Debasement, and Global Trends
  2. Bitcoin, Ether Open Week in Hushed Tone as Monthly Close Looms
  3. 65% Of Bitcoin Supply Unmoved In Over A Year, Signaling Bottom And Looming Upwards Price Action
  4. Cryptos Rise Amidst The Dollar's Retreat
  5. Rate Hike Fears Dampen Market Sentiment